Examkin

Question

Difficulty: HardPathology and Biopsy Interpretation

A 59-year-old man undergoes an excisional biopsy of a 1.4-cm asymmetric, variably pigmented skin lesion with irregular borders on his posterior shoulder. The dermatopathology report describes an asymmetric, poorly circumscribed proliferation of atypical melanocytes. Microscopic examination reveals single atypical melanocytes migrating into the upper layers of the epidermis (pagetoid spread). The dermal component shows a lack of melanocytic maturation, as the cells do not become smaller as they descend into the deep dermis, and frequent mitotic figures are noted near the deep margin. The Breslow thickness is measured at 1.7 mm. There is no surface ulceration or lymphovascular invasion identified. Based on the interpretation of these biopsy findings, which of the following statements are correct? (Select all that apply)

  1. The pagetoid upward migration of atypical melanocytes into the epidermis is a key architectural feature distinguishing this lesion from a benign nevus.Answer
  2. The Breslow depth reported in this biopsy is measured microscopically from the epidermal granular layer to the deepest aspect of the invasive tumor.Answer
  3. C
    The lack of melanocytic maturation in the deep dermis is a reassuring architectural feature characteristically seen in benign congenital melanocytic nevi.
  4. D
    Because the lesion lacks ulceration and lymphovascular invasion, the biopsy findings definitively represent a melanoma in situ.
  5. E
    The next appropriate diagnostic step for staging this patient based on the biopsy depth is a whole-body positron emission tomography scan.

Answer

The correct statements are that pagetoid upward migration of atypical melanocytes into the epidermis distinguishes this lesion from a benign nevus, and the Breslow depth is measured microscopically from the epidermal granular layer to the deepest aspect of the invasive tumor.
The diagnosis of melanoma is established through recognizing specific histopathologic criteria. Pagetoid spread, which is the upward migration of single atypical melanocytes into the superficial layers of the epidermis, is a classic and highly specific feature of melanoma that helps distinguish it from benign nevi. Furthermore, accurate staging relies heavily on the Breslow thickness, which pathologists standardize by measuring from the top of the epidermal granular layer (or the base of an ulcer, if ulcerated) to the deepest point of invasive tumor cells in the dermis. Both of these statements correctly reflect standard dermatopathology principles.

Step-by-Step Solution

1
Analyze the histopathologic findings provided in the vignette.
The report highlights an asymmetric proliferation of atypical melanocytes, pagetoid spread, lack of maturation, dermal mitoses, and an invasive Breslow depth of 1.7 mm without ulceration.
Identifying the key microscopic features is necessary to establish the diagnosis of invasive melanoma and differentiate it from benign melanocytic entities.
2
Differentiate benign versus malignant histologic characteristics in melanocytic lesions.
Pagetoid spread and a lack of dermal maturation are definitive signs of malignancy (melanoma), whereas normal maturation and restriction to the dermal-epidermal junction are signs of a benign nevus.
Accurate biopsy interpretation requires understanding how specific architectural features correlate with biologic behavior.
3
Evaluate the prognostic and staging implications of the reported Breslow thickness.
A Breslow depth of 1.7 mm defines the tumor as invasive and places it in the T2a category. This depth necessitates a sentinel lymph node biopsy for regional staging rather than immediate advanced distant imaging.
Breslow thickness determines the primary T-stage, which subsequently dictates appropriate surgical management and accurate diagnostic test sequencing.

Key Concept

Histopathologic interpretation of melanoma involves identifying features of malignancy (e.g., pagetoid spread, lack of maturation) and utilizing microscopic measurements (Breslow depth, measured from the granular layer) to guide accurate disease staging.
Rate this question

Topics

Pathology and Biopsy Interpretation

More questions from this topic